ARK Investment Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-309
Closed -$80K 269
2022
Q2
$80K Sell
309
-14
-4% -$4.69K ﹤0.01% 338
2022
Q1
$178K Buy
323
+34
+12% +$20.5K ﹤0.01% 332
2021
Q4
$191K Buy
+289
New +$221K ﹤0.01% 351

Other funds holding CDLX

ARK Investment Management's CDLX Position: Q3 2022 in Review

ARK Investment Management sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 309 shares — an estimated $80K sold.

ARK Investment Management first reported a position in CDLX in Q4 2021 and held it in 3 quarters. The position peaked at $191K in Q4 2021. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • ARK Investment Management reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • ARK Investment Management sold 309 Cardlytics shares in Q3 2022, an estimated $80K.
  • ARK Investment Management first reported a position in Cardlytics in Q4 2021 and held it in 3 quarters.
  • ARK Investment Management's Cardlytics position peaked at $191K in Q4 2021.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on ARK Investment Management's 13F filing for Q3 2022, filed 17 Oct 2022.